搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
clinicaltrialsarena
4 小时
Eirion sees success in ‘first-in-man’ topical hair-loss therapy trial
The company says the early trial of its hair-loss therapy saw patients benefit from six times more hair growth than placebo.
clinicaltrialsarena
4 小时
Insilico announces positive results from Phase I trials of AI-designed ISM5411
ISM5411 was well tolerated and demonstrated a favourable pharmokinetic profile in validating gut-restrictive properties.
clinicaltrialsarena
7 小时
Ryght AI and QPS to optimise global clinical trial processes
Ryght AI has announced a strategic collaboration with QPS Holdings for optimising clinical trial processes globally.
clinicaltrialsarena
7 小时
Early success for MBX in Phase I trial of GLP-1RA for hypoglycaemia
RA was well tolerated in the Phase I trial. Now MBX is planning a Phase II trial in post-bariatric hypoglycaemia patients.
clinicaltrialsarena
12 小时
BIAL’s first subject completes full dose regimen in Parkinson’s treatment trial
BIAL has completed the full dose regimen for the first subject in the Phase II ACTIVATE trial of BIA 28-6156, for Parkinson's treatment.
clinicaltrialsarena
10 小时
J&J reports positive topline outcomes from Phase III NSCLC combo therapy trial
J&J has reported positive topline outcomes from the MARIPOSA trial of RYBREVANT and LAZCLUZE combo for NSCLC treatment.
clinicaltrialsarena
1 天
Denali Therapeutics’ ALS therapy fails to meet primary endpoint in Phase II/III trial
Denali Therapeutics has reported that its Phase II/III HEALEY ALS Platform trial of DNL343 for ALS failed to meet its primary endpoint.
clinicaltrialsarena
1 天
Metsera announces positive results in newest Phase IIa GLP-1RA
The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over competitors’ more frequent regimens.
clinicaltrialsarena
1 天
VYNE Therapeutics completes enrolment in trial of gel for non-segmental vitiligo
VYNE Therapeutics has completed enrolment in the randomised Phase IIb clinical trial of VYN201 gel for treating non-segmental vitiligo.
clinicaltrialsarena
1 天
Study finds restrictive clinical trial criteria excludes Lyme disease patients
Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.
clinicaltrialsarena
1 天
FDA kicks off new year with draft guidance on skin biopsies in trials
The US Food and Drug Administration has issued guidance urging sponsors and trial sites to consider the necessity of the invasive procedure.
clinicaltrialsarena
1 天
CytoMed Therapeutics and SunAct to conduct solid tumour treatment trial in India
CytoMed Therapeutics has signed a business and research collaboration agreement with SunAct Cancer Institute for a clinical trial in India.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈